Insyce

About:

Inces is a biotech enterprise focusing on bio-separation technology.

Website: https://www.inscinstech.com.cn

Top Investors: Qiming Venture Partners, Matrix Partners China, Addor Capital, Lucion, Dynamic Balance Capital

Description:

Insyce creates equipment and apparatus for science. Its business strives to provide tools and technology for bio labs that monitor the environment to deliver accurate data and speedy chemical analysis while keeping lab costs down for their clients. It is dedicated to providing upper biological separation equipment and chemical analysis tools for global clients, cutting down on client operating expenses, and adding value for clients.

Total Funding Amount:

219M CNY

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

2017-01-09

Contact Email:

info(AT)inscinstech.com.cn

Founders:

Number of Employees:

251-500

Last Funding Date:

2023-01-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai